research results

Towards better medicines for children: PedCRIN project builds research infrastructure

PARIS (31 January 2017) – The European Clinical Research Infrastructure Network (ECRIN) has announced the launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN). The three-year project brings together ECRIN and the founding partners of the European Paediatric Clinical Trial Research Infrastructure (EPCT-RI) to develop capacity for the management of multinational paediatric clinical trials. Children [...]

By mariangela|2017-04-14T16:03:43+00:00January 31st, 2017|News, Press Releases|

Access to the drug: a two-speed Europe?

Access to the drug and reimbursement: a two-speed Europe? We talked about it to Dr. Enrico Bosone, president of SIAR (Italian Society for Regulatory Activities), a non-profit organization whose membership comprises about 200 professionals in Italy involved in regulatory activities related to the regulation of those products, including drugs, which require a production and/or marketing [...]

By admin|2017-01-03T11:18:01+00:00March 1st, 2016|News|

“The Italian Multiregional Thalassemia Registry: centers characteristics, services and patients’ population”, published on Hematology

The results of the project “HTA-Thal, Inter-regional Network for Thalassemia: HTA for the diagnostic and therapeutic intervention for iron overload”, a public funded project promoted in 2008 by the Minister of Health, has been published on Hematology. The project, co-funded by Fondazione Giambrone and coordinated by the Region of Basilicata, was aimed at creating a “Multiregional Network [...]

By mariangela|2016-02-11T10:37:34+00:00February 11th, 2016|News|

“Clinical Trials in Paediatrics — Regulatory and Methodological Aspects” chapter is now online!

On June, 2015, the chapter entitled "Clinical Trials in Paediatrics — Regulatory and Methodological Aspects" and included in the book Drug Discovery and Development - From Molecules to Medicine, ISBN 978-953-51-2128-2, edited by Omboon Vallisuta and Suleiman Olimat has been released online. This chapter has been written with the contribution of Adriana Ceci, Viviana Giannuzzi, [...]

By admin|2017-01-03T11:18:08+00:00August 7th, 2015|News|

DEEP Open Meeting in Tirana: Networking and Innovation for local development

The Open Meeting of the DEEP (DEferiprone Evaluation in Paediatrics) project will be held in Tirana at the Hotel Tirana International on May 18th, 2015 DEEP is a 4-year European research Project (FP7) coordinated by CVBF and comprises 28 recruiting sites located in 5 European Countries (Albania, Cyprus, Greece, Italy and United Kingdom) and 5 [...]

By mariangela|2017-01-03T11:18:09+00:00May 18th, 2015|News|

Press Conference at UniBA

On December 10th 2014, a press conference was held at the rectorate of the University of Bari Aldo Moro with the aim to sign the framework agreement for the scientific collaboration between the University of Bari (UniBA), the Gianni Benzi Pharmacological Research Foundation (FGB) and the Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF). On that [...]

By mariangela|2017-01-03T11:18:11+00:00January 20th, 2015|News|

13th National Report on Clinical Trials of Drugs in Italy, 2014

The Italian Medicines Agency (AIFA) has published the 13th National Report on Clinical Trials of Drugs in Italy, which contains data from 2013 and provides a clear and objective picture of the clinical trials in Italy, highlighting the presence of centres performing clinical trials in the field of pharmacology, the types of research conducted and [...]

By mariangela|2017-01-03T11:18:11+00:00January 19th, 2015|News|

DEEP-2 Efficacy/Safety Study Newsletter – Issue 4

The fourth issue of the newsletter pertaining to DEEP-2 clinical trial, one of the three studies at the bottom of the DEEP Project (DEferiprone Evaluation in Paediatrics) was published on January 7th, 2015. This Newsletter highlights the main progresses achieved in the study advancement since July 2014 and provides an overview on the status of the participant [...]

By mariangela|2017-01-03T11:18:11+00:00January 13th, 2015|News|

European Medicines Agency policy on publication of clinical data

In October 2014, the European Medicines Agency (EMA) Board adopted the wording of the Agency’s new policy intended to further increase the availability of clinical trials data for medicinal products authorised in the EU: European Medicines Agency policy on publication of clinical data for medicinal products for human use Q&A on the European Medicines Agency [...]

By mariangela|2015-11-26T15:42:19+00:00December 30th, 2014|News|

NEOMERO1 Clinical Trial Status

The core strategy of the NEOMERO Project includes the combination of two clinical trials: Neomero1 (an open-label, randomised, multicenter, comparator-controlled study to evaluate the PK, efficacy and safety of meropenem as compared with standard antibiotic therapy in neonates and infants aged < 3 months treated in neonatal intensive care units (NICU) for late onset sepsis [...]

By admin|2015-11-26T15:48:55+00:00December 27th, 2014|News|